← Open Payments lookup

RACHEL KENT: Open Payments

NPI 1548982739 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$253 in 14 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $27 · 2025 $253

Food & beverage: $253
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.2$52
AstraZeneca Pharmaceuticals LP2$33
Xeris Pharmaceuticals, Inc.1$30
MAYNE PHARMA COMMERCIAL LLC4$25
IDORSIA PHARMACEUTICALS US INC1$25
Novo Nordisk Inc1$24
GlaxoSmithKline, LLC.1$23
Hologic Sales and Service, LLC1$23
ABBVIE INC.1$17

Products named: TRINTELLIX, AIRSUPRA, KEVEYIS, Quviviq, Wegovy, AREXVY, APTIMA, UBRELVY.

Industry payments across PA — which companies pay providers there.